Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 1)

Drug Discovery Today

Volumn 6, Issue 3, 2001, Pages 150-156

  Kusuhara, Hiroyuki ^a   Sugiyama, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PROTEIN; ANTIEMETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DAUNORUBICIN; DOXORUBICIN; DRUG CARRIER; ETOPOSIDE; FLEROXACIN; GLUCOCORTICOID; GLUCOSE TRANSPORTER; GLUTATHIONE; GLYCOPROTEIN P; IVERMECTIN; LOPERAMIDE; MORPHINE; MULTIDRUG RESISTANCE PROTEIN; PENICILLIN G; PHENYTOIN; QUINIDINE; RANITIDINE; SOMATOSTATIN; TAUROCHOLIC ACID; UNINDEXED DRUG; VINBLASTINE; VINCA ALKALOID; VINCRISTINE; XENOBIOTIC AGENT; ZIDOVUDINE;

BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN CAPILLARY; DRUG PENETRATION; DRUG TRANSPORT; HUMAN; HYDROPHILICITY; NONHUMAN; REVIEW; TIGHT JUNCTION; TRANSPORT KINETICS;

EID: 0035253135     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(00)01632-9     Document Type: Review

References (56)

1. Transport of small molecules through the blood-brain barrier: biology and methodology
2. The blood-brain barrier efflux transporters as a detoxifying system for the brain
3. Role of efflux transport across the blood-brain barrier and blood-cerebrospinal fluid barrier on the disposition of xenobiotics in the CNS
4. Carrier-mediated or specialized transport of drugs across the blood-brain barrier
5. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability
6. P-Glycoprotein, a gatekeeper in the blood-brain barrier
7. Drug transport in the mammalian CNS: multiple complex systems. A critical analysis and commentary
8. In vivo study of the elimination from rat brain of an intracerebrally formed xenobiotic metabolite, 1-naphthyl-β-D-glucuronide
9. Saturable efflux of the peptides RC160 and Tyr-MIF-1 by different parts of the blood-brain barrier
10. Brain efflux index as a novel method of analyzing efflux transport at the blood-brain barrier
11. Selective brain to blood efflux transport of para-aminohippuric acid across the blood-brain barrier: in vivo evidence by use of the brain efflux index method
12. In vivo evidence for carrier-mediated efflux transport of 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system
13. Efflux of taurocholic acid across the blood-brain barrier: interaction with cyclic peptides
14. P-Glycoprotein mediates the efflux of quinidine across the blood-brain barrier
15. Efflux transport of a new quinolone antibacterial agent, HSR903, across the blood-brain barrier
16. Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport
17. Multidrug resistance
18. The role of P-glycoprotein and canalicular multispecific organic anion transporter in the hepatobiliary excretion of drugs
19. Regulation of initial vinblastine influx by P-glycoprotein
20. Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates
21. Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice
22. Renal secretion of xenobiotics mediated by P-glycoprotein: importance to renal function in health and exploitation for targeted drug delivery to epithelial cysts in polycystic kidney disease
23. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites
24. Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption
25. Modulation of doxorubicin concentration by cyclosporin A in brain and testicular barrier tissues expressing P-glycoprotein in rats
26. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice
27. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues
28. P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells
29. Multidrug resistance-related transport proteins in isolated human brain microvessels and in cells cultured from these isolates
30. Specialized localization of P-glycoprotein recognized by MRK16 monoclonal antibody in endothelial cells of the brain and the spinal cord
31. Functional involvement of P-glycoprotein in blood-brain barrier
32. Brain microvascular and astrocyte localization of P-glycoprotein
33. Choroid plexus epithelial expression of MDR1 P-glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier
34. Effect of P-glycoprotein modulation with cyclosporin A on cerebrospinal fluid penetration of doxorubicin in non-human primates
35. 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein
36. Biology of the multidrug resistance-associated protein, MRP
37. Structural, mechanistic and clinical aspects of MRP1
38. Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells
39. Functional reconstitution of substrate transport by purified multidrug resistance protein MRP1 (ABCC1) in phospholipid vesicles
40. Multidrug resistance protein 1 protects the oropharyngeal mucosal layer and the testicular tubules against drug-induced damage
41. Immunohistochemical detection of multidrug resistance protein in human lung cancer and normal lung
42. Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells
43. Dexamethasone regulation of P-glycoprotein activity in an immortalized rat brain endothelial cell line, GPNT
44. Characterization of efflux transport of organic anions in a mouse brain capillary endothelial cell line
45. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier
46. Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells
47. The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides
48. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs
49. Molecular aspects of hepatobiliary transport
50. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver
51. The choroid plexus epithelium is the site of the organic anion transport protein in the brain
52. Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain
53. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier
54. Cellular and molecular aspects of drug transport in the kidney
55. Structure of renal organic anion and cation transporters
56. The multispecific organic anion transporter (OAT) family